| Company | Location | Amount | Technology Focus (Date) |
| (C$, M)* | |||
| Base4 Bioinformatics Inc. | Toronto | 4.5 | Bioinformatics (1/98) |
| GlycoDesign Inc. | Toronto | 16.35 | Carbohydrate-based thera- |
| peutics (5/98) | |||
| MethylGene Inc. | Montreal | 15.8 | Antisense technologies (3/98) |
| Morphometrix Inc. | Toronto | 13 | Automated analyzer for |
| Pap smears (6/98) | |||
| Neurochem Inc. | Montreal | 10 | Alzheimer's disease |
| therapeutics (4/98) | |||
| RTP Pharma Inc. | Montreal | 20** | Insoluble drug delivery |
| technology (6/98) | |||
| Synapse Technologies Inc. | Vancouver, | 5 | Alzheimer's disease |
| British Columbia | diagnostics (4/98) | ||
| Theralipids Inc. | Montreal | 3.9 | Novel antibiotics (5/98) |
| TOTAL: | C$88.55M | ||
| NOTES: | |||
| * Amounts are quoted in Canadian dollars. The exchange rate on 9/10/98 was C$1.52/US$1. | |||
| ** RTP Pharma Inc. received C$14.6M in financing in 6/98, followed by an additional C$5.4M, for an aggregate of C$20M raised in two transactions. | |||
